Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
Make a selection below to explore our full database of 3 results matching: "SA Burnett-Bowie"
ACE Reports
(3 Reports)
ACE Reports
Our Al driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Metabolic Disorders
Combination therapy improves site-specific BMD vs. teriparatide & denosumab monotherapies
J Clin Densitom. 2016 Jul-Sep;19(3):346-51
Combination therapy improves site-specific BMD vs. teriparatide & denosumab monotherapies
J Clin Densitom. 2016 Jul-Sep;19(3):346-51
General Orthopaedics
Denosumab and teriparatide significantly improves BMD in patients with osteoporosis
J Clin Endocrinol Metab. 2014 May;99(5):1694-700
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Denosumab and teriparatide significantly improves BMD in patients with osteoporosis
J Clin Endocrinol Metab. 2014 May;99(5):1694-700
Osteoarthritis
Combined teriparatide and denosumab treatment increased BMD in postmenopausal osteoporosis
Lancet. 2013 Jul 6;382(9886):50-6. doi: 10.1016/S0140-6736(13)60856-9. Epub 2013 May 15
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Combined teriparatide and denosumab treatment increased BMD in postmenopausal osteoporosis
Lancet. 2013 Jul 6;382(9886):50-6. doi: 10.1016/S0140-6736(13)60856-9. Epub 2013 May 15